-
-
-
-
-
-
-
BTIG Downgrades Aardvark Therapeutics Inc (AARD) to Neutral
-
-
-
-
-
-
-
Aardvark Therapeutics Inc (AARD) PT Lowered to $8 at B.Riley
-
-
-
-
-
-
-
Morgan Stanley Downgrades Aardvark Therapeutics Inc (AARD) to Equalweight
-
-
-
-
-
-
-
William Blair Starts Aardvark Therapeutics Inc (AARD) at Outperform
-
-
-
-
-
-
-
Aardvark Therapeutics, Inc. (AARD) Tops Q3 EPS by 2c
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Aardvark Therapeutics Inc (AARD)
-
-
-
-
-
-
-
Aardvark Therapeutics Inc (AARD) PT Raised to $26 at BofA Securities
-
484,013 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


